4.5 Article

Distinct patterns of increased translocator protein in posterior cortical atrophy and amnestic Alzheimer′s disease

期刊

NEUROBIOLOGY OF AGING
卷 51, 期 -, 页码 132-140

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2016.12.006

关键词

Alzheimer ' s disease; Neuroinflammation; PET imaging

资金

  1. Intramural Research Program at the National Institute of Mental Health, National Institutes of Health (IRP- NIMH- NIH) [ZIAMH002852, ZIAMH0022793, NCT00955422, NCT00613119]

向作者/读者索取更多资源

We sought to determine whether patients with posterior cortical atrophy (PCA) demonstrate a pattern of binding to translocator protein 18 kDa, a marker of microglial activation, that is distinct from that in patients with amnestic presentation of Alzheimer's disease (AD). Eleven PCA patients, 11 amnestic AD patients, and 15 age-matched controls underwent positron emission tomography with C-11-PBR28 to measure translocator protein 18 kDa. PCA patients showed greater C-11-PBR28 binding than controls in occipital, posterior parietal, and temporal regions. In contrast, amnestic AD patients showed greater C-11-PBR28 binding in inferior and medial temporal cortex. Increased C-11-PBR28 binding overlapped with reduced cortical volume for both PCA and amnestic AD patients, and with areas of reduced glucose metabolism in PCA patients. While both patient groups showed diffuse amyloid binding, PCA patients showed greater binding than amnestic AD patients in bilateral occipital cortex. These results suggest that microglial activation is closely associated with neurodegeneration across different subtypes of AD. (C) Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort

Angelina J. Polsinelli, Ryan J. Wonderlin, Dustin B. Hammers, Alex Pena Garcia, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah, Laurel Beckett, Sujuan Gao, Sophia Wang, Kala Kirby, Paige E. Logan, Paul Aisen, Jeffrey L. Dage, Tatiana Foroud, Percy Griffin, Leonardo Iaccarino, Joel H. Kramer, Robert Koeppe, Walter A. Kukull, Renaud La Joie, Nidhi S. Mundada, Melissa E. Murray, Kelly Nudelman, David N. Soleimani-Meigooni, Malia Rumbaugh, Arthur W. Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph Masdeu, Mario F. Mendez, Kyle Womack, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Steven Salloway, Sharon J. Sha, Raymond S. Turner, Thomas S. Wingo, David A. Wolk, Maria C. Carrillo, Bradford C. Dickerson, Gil D. Rabinovici, Liana G. Apostolova

Summary: We investigated NPS and psychotropic medication use in individuals with EOAD using data from LEADS. Affective behaviors were most common in EOAD, while tension and impulse control behaviors were more common in EOnonAD. Psychotropic medication use was higher in EOnonAD. Overall, NPS burden and psychotropic medication use were higher in EOnonAD compared to EOAD participants.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection

Dustin Hammers, Ani Eloyan, Alexander Taurone, Maryanne Thangarajah, Laurel Beckett, Sujuan Gao, Kala Kirby, Paul L. Aisen, Jeffrey Dage, Tatiana Foroud, Percy T. Griffin, Lea R. Grinberg, Clifford Jack Jr, Joel Kramer, Robert A. Koeppe, Walter Kukull, Nidhi S. Mundada, Renaud N. La Joie, David Soleimani-Meigooni, Leonardo E. Iaccarino, Melissa Murray, Kelly J. Nudelman, Angelina Polsinelli, Malia Rumbaugh, Arthur Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza S. Atri, Gregory Day, Ranjan R. Duara, Neill S. Graff-Radford, Lawrence T. Honig, David Jones, Joseph F. Masdeu, Mario Mendez, Kyle Womack, Erik U. Musiek, Chiadi Onyike, Meghan Riddle, Emily Rogalski, Steven J. Salloway, Sharon Sha, Raymond Scott S. Turner, Thomas A. Wingo, David C. Wolk, Maria C. Carrillo, Bradford D. Dickerson, Gil G. Rabinovici, Liana Apostolova

Summary: This study provides a comprehensive understanding of early-onset Alzheimer's disease (EOAD) by profiling the baseline characteristics of EOAD patients. The study found that EOAD patients had worse cognitive performance and higher rates of APOE epsilon 4 carrier status. Amnestic presentation was common among EOAD patients, along with other clinical phenotypes.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Learning slopes in early-onset Alzheimer's disease

Dustin Hammers, Sara Nemes, Taylor Diedrich, Ani Eloyan, Kala Kirby, Paul Aisen, Joel Kramer, Kelly Nudelman, Tatiana Foroud, Malia Rumbaugh, Alireza S. Atri, Gregory Day, Ranjan R. Duara, Neill S. Graff-Radford, Lawrence T. Honig, David C. Jones, Joseph F. Masdeu, Mario Mendez, Erik U. Musiek, Chiadi Onyike, Meghan Riddle, Emily Rogalski, Steve J. Salloway, Sharon J. Sha, Raymond Scott Turner, Sandra S. Weintraub, Thomas A. Wingo, David Wolk, Bonnie C. Wong, Maria C. Carrillo, Bradford D. Dickerson, Gil G. Rabinovici, Liana Apostolova

Summary: This study investigated the limitations of learning slopes in early-onset dementias and aimed to highlight the sensitivity of learning slopes in discriminating disease severity in cognitively normal participants and those diagnosed with early-onset dementia. The results showed that learning slopes are highly sensitive to early-onset dementias, even when controlling for the effect of total learning and cognitive severity. The rating for the importance of this study is 8 out of 10.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Nigrosome 1 visibility and its association with nigrostriatal dopaminergic loss in Parkinson's disease

Han-Kyeol Kim, Tae Won Kim, Min Seok Baek, Eung Yeop Kim, Young Hee Sung, Jae Hoon Lee, Young Hoon Ryu, Sung Jun Ahn, Han Soo Yoo, Chul Hyoung Lyoo

Summary: In this study, the visibility of NG1 in SMwI was found to be associated with the degree of nigrostriatal degeneration in PD patients. It was concluded that SMwI can be used for diagnosing PD only after the onset of motor symptoms.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Article Immunology

Inhibition of discoidin domain receptor (DDR)-1 with nilotinib alters CSF miRNAs and is associated with reduced inflammation and vascular fibrosis in Alzheimer's disease

Max Stevenson, Rency Varghese, Michaeline L. Hebron, Xiaoguang Liu, Nick Ratliff, Amelia Smith, R. Scott Turner, Charbel Moussa

Summary: Treatment with nilotinib in patients with mild-moderate Alzheimer's disease for 12 months can reduce amyloid plaque and cerebrospinal fluid amyloid levels, as well as attenuate hippocampal volume loss. This is achieved by inhibiting DDR-1 gene expression and activity, leading to a reduction in inflammation. Nilotinib may not only clear amyloid and tau but also reduce cerebrovascular fibrosis.

JOURNAL OF NEUROINFLAMMATION (2023)

Article Clinical Neurology

Obstructive Sleep Apnea and Striatal Dopamine Availability in Parkinson's Disease

Yoon-Sang Oh, Joong-Seok Kim, Chul Hyoung Lyoo, Hosung Kim

Summary: This study found that Parkinson's disease patients with obstructive sleep apnea had significantly lower dopamine availability in the caudate nucleus compared to those without obstructive sleep apnea. This association was more pronounced in female patients. However, there was no difference in dopamine availability in other structures (putamen, globus pallidus, thalamus) between the two groups.

MOVEMENT DISORDERS (2023)

Article Clinical Neurology

Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study

Jeffrey Dage, Ani Eloyan, Maryanne Thangarajah, Dustin B. Hammers, Anne M. Fagan, Julia D. Gray, Suzanne E. Schindler, Casey Snoddy, Kelly N. H. Nudelman, Kelley M. Faber, Tatiana Foroud, Paul Aisen, Percy T. Griffin, Lea T. Grinberg, Leonardo Iaccarino, Kala Kirby, Joel Kramer, Robert A. Koeppe, Walter A. Kukull, Renaud La Joie, Nidhi S. Mundada, Melissa E. Murray, Malia Rumbaugh, David N. Soleimani-Meigooni, Arthur W. Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza A. Atri, Laurel A. Beckett, Gregory S. Day, Neill R. Graff-Radford, Ranjan S. Duara, Lawrence S. Honig, David T. Jones, Joseph C. Masdeu, Mario F. Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J. Sha, Raymond S. Turner, Thomas S. Wingo, David A. Wolk, Kyle B. Womack, Maria C. Carrillo, Bradford C. Dickerson, Gil D. Rabinovici, Liana G. Apostolova

Summary: This study provides a comprehensive analysis of cerebrospinal fluid biomarkers in early-onset Alzheimer's disease (EOAD) and identifies significant differences in biomarker concentrations between different groups. Most biomarkers are found to be correlated with cognition. These findings have important implications for the design of clinical trials for EOAD.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer′s Disease Study (LEADS)

Hanna Cho, Nidhi S. Mundada, Liana G. Apostolova, Maria C. Carrillo, Ranjani Shankar, Alinda N. Amuiri, Ehud Zeltzer, Charles C. Windon, David N. Soleimani-Meigooni, Jeremy A. Tanner, Courtney Lawhn Heath, Orit H. Lesman-Segev, Paul Aisen, Ani Eloyan, Hye Sun Lee, Dustin B. Hammers, Kala Kirby, Jeffrey L. Dage, Anne Fagan, Tatiana Foroud, Lea T. Grinberg, Clifford R. Jack, Joel Kramer, Walter A. Kukull, Melissa E. Murray, Kelly Nudelman, Arthur Toga, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph Masdeu, Mario Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily J. Rogalski, Stephen Salloway, Sharon Sha, Raymond Scott Turner, Thomas S. Wingo, David A. Wolk, Robert Koeppe, Leonardo Iaccarino, Bradford C. Dickerson, Renaud La Joie, Gil D. Rabinovici

Summary: This study describes the baseline amyloid-beta and tau-PET results in early-onset Alzheimer's disease. The results show that amyloid-PET can help distinguish early-onset Alzheimer's disease from other cognitive impairments, and tau-PET signal is elevated in a parietal-predominant pattern with higher burden in younger female patients.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease

Sara Nemes, Paige E. Logan, Mohit K. Manchella, Nidhi S. Mundada, Renaud La Joie, Angelina J. Polsinelli, Dustin B. Hammers, Robert A. Koeppe, TatianaM. Foroud, Kelly N. Nudelman, Ani Eloyan, Leonardo Iaccarino, Valerie Dorsant-Ardon, Alexander Taurone, Maryanne Thangarajah, Jeffery L. Dage, Paul Aisen, Lea T. Grinberg, Clifford R. Jack, Joel Kramer, Walter A. Kukull, Melissa E. Murray, Malia Rumbaugh, David N. Soleimani-Meigooni, Arthur Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph Masdeu, Mario F. Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J. Sha, Raymond S. Turner, Thomas S. Wingo, Kyle B. Womack, David A. Wolk, Gil D. Rabinovici, Maria C. Carrillo, Bradford C. Dickerson, Liana G. Apostolova

Summary: This study investigated the predictive ability of sex and APOE epsilon 4 carrier status on the pathological burden in early-onset Alzheimer's disease. The results showed that EOAD females had higher amyloid and tau PET burdens compared to males, and EOAD female APOE epsilon 4 non-carriers had higher amyloid PET burdens and greater gray matter atrophy compared to carriers.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

Influence of amyloid and diagnostic syndrome on non-traditionalmemory scores in early-onset Alzheimer's disease

Justin Bushnell, Dustin B. Hammers, Paul Aisen, Jeffrey L. Dage, Ani Eloyan, Tatiana Foroud, Lea T. Grinberg, Leonardo Iaccarino, Clifford R. Jack Jr, Kala Kirby, Joel Kramer, Robert Koeppe, Walter A. Kukull, Renaud La Joie, Nidhi S. Mundada, Melissa E. Murray, Kelly Nudelman, Malia Rumbaugh, David N. Soleimani-Meigooni, Arthur Toga, Alexandra Touroutoglou, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph Masdeu, Mario Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Steven Salloway, Sharon Sha, Raymond S. Turner, Thomas S. Wingo, David A. Wolk, Maria C. Carrillo, Bradford C. Dickerson, Gil D. Rabinovici, Liana G. Apostolova, David G. Clark

Summary: This study assessed the influence of amyloid and diagnostic syndrome on memory scores in early-onset Alzheimer's disease (EOAD) using the Rey Auditory Verbal Learning Test (RAVLT). The results showed that the RAVLT measures were sensitive to the effects of amyloid and syndrome in EOAD.

ALZHEIMERS & DEMENTIA (2023)

Review Clinical Neurology

The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (leads) Cohort

Alexandra Touroutoglou, Yuta Katsumi, Michael Brickhouse, Alexander Zaitsev, Ryan Eckbo, Paul Aisen, Laurel Beckett, Jeffrey L. Dage, Ani Eloyan, Tatiana Foroud, Bernardino Ghetti, Percy Griffin, Dustin Hammers, Clifford R. Jack, Joel H. Kramer, Leonardo Iaccarino, Renaud La Joie, Nidhi S. Mundada, Robert Koeppe, Walter A. Kukull, Melissa E. Murray, Kelly Nudelman, Angelina J. Polsinelli, Malia Rumbaugh, David N. Soleimani-Meigooni, Arthur Toga, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph C. Masdeu, Mario F. Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon Sha, R. Scott Turner, Thomas S. Wingo, David A. Wolk, Kyle Womack, Maria C. Carrillo, Gil D. Rabinovici, Liana G. Apostolova, Bradford C. Dickerson, LEADS Consortium

Summary: MRI research has advanced understanding of neurodegeneration in sporadic early-onset Alzheimer's disease, with the EOAD-signature atrophy replicated across different cohorts and associated with the severity of cognitive impairment. This suggests that EOAD-signature atrophy could be a reliable biomarker for AD-related neurodegeneration in clinical trials for EOAD.

ALZHEIMERS & DEMENTIA (2023)

Review Clinical Neurology

White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS)

Ani Eloyan, Maryanne Thangarajah, Na J. An, Bret J. L. Borowski, Ashritha L. Reddy, Paul L. Aisen, Jeffrey L. Dage, Tatiana Foroud, Bernardino Ghetti, Percy Griffin, Dustin Hammers, Leonardo R. Iaccarino, Clifford R. Jack, Kala Kirby, Joel Kramer, Robert A. Koeppe, Walter A. Kukull, Renaud La Joie, Nidhi S. E. Mundada, Melissa E. Murray, Kelly Nudelman, Malia N. Rumbaugh, David N. Soleimani-Meigooni, Arthur Toga, Alexandra Touroutoglou, Alireza S. Atri, Gregory S. Day, Ranjan R. Duara, Neill R. S. Graff-Radford, Lawrence S. T. Honig, David T. Jones, Joseph F. Masdeu, Mario F. Mendez, Erik U. Musiek, Chiadi U. Onyike, Emily Rogalski, Stephen Salloway, Sharon S. Sha, Raymond S. S. Turner, Thomas S. A. Wingo, David A. Wolk, Kyle Womack, Laurel Beckett, Sujuan C. Gao, Maria C. Carrillo, Gil G. Rabinovici, Liana G. Apostolova, Brad Dickerson, Prashanthi Vemuri, LEADS Consortium

Summary: This study compared white matter hyperintensities (WMHs) in early-onset Alzheimer's disease (EOAD) with cognitively normal (CN) and early-onset amyloid-negative cognitively impaired (EOnonAD) groups. The results showed that EOAD patients had higher WMH volumes compared to CN and EOnonAD patients, and WMH volume was positively correlated with cognitive impairment and tau burden.

ALZHEIMERS & DEMENTIA (2023)

Review Clinical Neurology

Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort

Kelly N. H. Nudelman, Trever Jackson, Malia Rumbaugh, Ani Eloyan, Marco Abreu, Jeffrey L. Dage, Casey Snoddy, Kelley M. Faber, Tatiana Foroud, Dustin B. Hammers, Alexander Taurone, Maryanne Thangarajah, Paul Aisen, Laurel Beckett, Joel Kramer, Robert Koeppe, Walter A. Kukull, Melissa E. Murray, Arthur W. Toga, Prashanthi Vemuri, Alireza Atri, Gregory S. Day, Ranjan Duara, Neill R. Graff-Radford, Lawrence S. Honig, David T. Jones, Joseph C. Masdeu, Mario Mendez, Erik Musiek, Chiadi U. Onyike, Meghan Riddle, Emily Rogalski, Stephen Salloway, Sharon J. Sha, R. Scott Turner, Thomas S. Wingo, David A. Wolk, Maria C. Carrillo, Bradford C. Dickerson, Gil D. Rabinovici, Liana G. Apostolova

Summary: The Longitudinal Early-onset Alzheimer's Disease Study aims to investigate the genetic causes of early onset cognitive impairment. The study found that the participants had a low frequency of common pathogenic variants.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment

Mark Monane, Kim G. Johnson, B. Joy Snider, Raymond S. Turner, Jonathan D. Drake, Demetrius M. Maraganore, James L. Bicksel, Daniel H. Jacobs, Julia L. Ortega, Joni Henderson, Yan Jiang, Shuguang Huang, Justine Coppinger, Ilana Fogelman, Tim West, Joel B. Braunstein

Summary: The objective of this study was to examine the patient selection and result interpretation of the PrecivityAD (R) blood test in clinicians evaluating symptomatic patients for Alzheimer's disease or other causes of cognitive decline. The study found that the test had clinical utility in patient care and could be particularly relevant with the introduction of new Alzheimer's disease therapies.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2023)

Article Neurosciences

Exploring the link between essential tremor and Parkinson's disease

Sang-Won Yoo, Seunggyun Ha, Chul Hyoung Lyoo, Yuna Kim, Ji-Yeon Yoo, Joong-Seok Kim

Summary: This study explores the interaction between essential tremor (ET) and Parkinson's disease (PD), finding that patients with PD preceded by ET may exhibit different characteristics from those with pure ET or PD. Patients with PD preceded by ET show typical striatal pathology, but with a delay in noradrenergic impairment. ET patients have similar patterns of presynaptic dopamine transporter deficits as PD patients.

NPJ PARKINSONS DISEASE (2023)

Article Geriatrics & Gerontology

Frontoparietal function and underlying structure reflect capacity for motor skill acquisition during healthy aging

Sarah N. Kraeutner, Cristina Rubino, Jennifer K. Ferris, Shie Rinat, Lauren Penko, Larissa Chiu, Brian Greeley, Christina B. Jones, Beverley C. Larssen, Lara A. Boyd

Summary: This study examined the age-related changes in brain function and baseline brain structure that support motor skill acquisition. The findings showed that older adults experienced decreases in functional connectivity during motor skill acquisition, while younger adults experienced increases. Additionally, regardless of age group, lower baseline microstructure in a frontoparietal tract was associated with slower motor skill acquisition.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Genetic analyses in multiplex families confirms chromosome 5q35 as a risk locus for Alzheimer's Disease in individuals of African Ancestry

Karen Nuytemans, Farid Rajabli, Melissa Jean-Francois, Jiji Thulaseedhara Kurup, Larry D. Adams, Takiyah D. Starks, Patrice L. Whitehead, Brian W. Kunkle, Allison Caban-Holt, Jonathan L. Haines, Michael L. Cuccaro, Jeffery M. Vance, Goldie S. Byrd, Gary W. Beecham, Christiane Reitz, Margaret A. Pericak-Vance

Summary: This study conducted genetic research on African American AD families and identified a significant linkage signal associated with AD, highlighting the importance of diverse population-level genetic data in understanding the genetic determinants of AD.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Improvement of mnemonic discrimination with acute light exercise is mediated by pupil-linked arousal in healthy older adults

Kazuya Suwabe, Ryuta Kuwamizu, Kazuki Hyodo, Toru Yoshikawa, Takeshi Otsuki, Asako Zempo-Miyaki, Michael A. Yassa, Hideaki Soya

Summary: Physical exercise has a positive impact on hippocampal memory decline with aging. Recent studies have shown that even light exercise can improve memory and this improvement is mediated by the ascending arousal system. This study aimed to investigate the effects of light-intensity exercise on hippocampal memory function in healthy older adults and found that pupil dilation during exercise played a role in the memory improvement.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Metformin, age-related cognitive decline, and brain pathology

Ajay Sood, Ana Werneck Capuano, Robert Smith Wilson, Lisa Laverne Barnes, Alifiya Kapasi, David Alan Bennett, Zoe Arvanitakis

Summary: The objective of this study was to explore the impact of metformin on cognition and brain pathology. The results showed that metformin users had slower decline in global cognition, episodic memory, and semantic memory compared to non-users. However, the relationship between metformin use and certain brain pathology remains uncertain.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Sex modifies effects of imaging and CSF biomarkers on cognitive and functional outcomes: a study of Alzheimer's disease

Brian N. Lee, Junwen Wang, Molly A. Hall, Dokyoon Kim, Shana D. Stites, Li Shen

Summary: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory and functional impairments. This study analyzed participants from the Alzheimer's Disease Neuroimaging Initiative and found differential associations between cerebral spinal fluid (CSF)/neuroimaging biomarkers and cognitive/functional outcomes, as well as variations between sexes. These findings suggest that sex differences may play a role in the development of AD.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment

Madeline R. Hale, Rebecca Langhough, Lianlian Du, Bruce P. Hermann, Carol A. Van Hulle, Margherita Carboni, Gwendlyn Kollmorgenj, Kristin E. Basche, Davide Bruno, Leah Sanson-Miles, Erin M. Jonaitis, Nathaniel A. Chin, Ozioma C. Okonkwo, Barbara B. Bendlin, Cynthia M. Carlsson, Henrik Zetterberg, Kaj Blennow, Tobey J. Betthauser, Sterling C. Johnson, Kimberly D. Mueller

Summary: This study demonstrates a relationship between cerebrospinal fluid biomarkers and the ability to recall proper names in the preclinical phase of Alzheimer's disease.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Auditory robustness and resilience in the aging auditory system of the desert locust

Thomas T. Austin, Christian L. Thomas, Ben Warren

Summary: This study investigated the effects of age on the robustness and resilience of auditory system using the desert locust. The researchers found that gene expression changes were mainly influenced by age rather than noise exposure. Both young and aged locusts were able to recover their auditory nerve function within 48 hours of noise exposure, but the recovery of transduction current magnitude was impaired in aged locusts. Key genes responsible for robustness to noise exposure in young locusts and potential candidates for compensatory mechanisms in auditory neurons of aged locusts were identified.

NEUROBIOLOGY OF AGING (2024)